C18 NC-TNP
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
C6mPhE-383 is a meta-substituted aromatic, disulfide-containing ionizable lipid based on the 383 polyamine core. In the cited mouse study, LNPs containing C6mPhE-383 delivered reporter mRNA to draining lymph nodes after intramuscular administration with reduced liver accumulation and transfection relative to SM-102 LNPs. The investigators also evaluated this lipid in an mRNA SARS-CoV-2 spike vaccination model and reported antigen-specific antibody and T-cell responses.
| CAS No. | Not available |
| Chemical Name | 3,3′,3″,3‴-((piperazine-1,4-diylbis(propane-3,1-diyl))bis(azanetriyl))tetrakis(1-(3-(hexyldisulfaneyl)phenoxy)propan-2-ol) |
| Synonyms | C6mPhE383;C6mPhE 383 |
| SMILES | CCCCCCSSc1cccc(OCC(O)CN(CCCN2CCN(CCCN(CC(O)COc3cccc(SSCCCCCC)c3)CC(O)COc3cccc(SSCCCCCC)c3)CC2)CC(O)COc2cccc(SSCCCCCC)c2)c1 |
| Formula | C70H112N4O8S8 |
| M.Wt | 1394.22 |
| Purity | >95% by ELSD-HPLC |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Yamagata HM, et al. Liver-Detargeted Aromatic Bioreducible mRNA Lipid Nanoparticles Confer Lymph Node Tropism and Robust Antigen-Specific Immunity. J Am Chem Soc (2026). doi:10.1021/jacs.6c00080 |
| Component | mol% | Role |
|---|---|---|
| C6mPhE-383 | 35 | Ionizable lipid |
| DOPE | 16 | Helper phospholipid |
| Cholesterol | 46.5 | Sterol |
| C14-PEG2000 | 2.5 | PEG lipid |
| Total | 100 | Supporting Information §1.10 |
At 0.05 mg/kg luciferase mRNA (1 µg) and 6 h after intramuscular dosing, the aroLNP series showed lymph-node transfection with less liver signal than the SM-102 comparator. C6mPhE-383 was selected for follow-up biodistribution experiments.
DiR-labeled C6mPhE-383 LNPs accumulated in draining iliac and inguinal lymph nodes with lower hepatic accumulation than SM-102 LNPs after intramuscular injection.
In a mouse SARS-CoV-2 spike mRNA prime–boost study (0.25 mg/kg, 5 µg mRNA; doses 3 weeks apart), C6mPhE-383 LNPs produced anti-RBD IgG and antigen-responsive T-cell responses. Spleens and serum were assessed 2 weeks after boosting.
In a separate luciferase mRNA experiment, circulating IL-6, TNF and IFN-γ were lower for C6mPhE-383 LNPs than for the SM-102 LNP comparator under the reported conditions.
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 7.1725 mL | 1.4345 mL | 0.7172 mL |
| 25 mg | 17.9311 mL | 3.5862 mL | 1.7931 mL |
| 50 mg | 35.8623 mL | 7.1725 mL | 3.5862 mL |
| 100 mg | 71.7246 mL | 14.3449 mL | 7.1725 mL |
| 250 mg | 179.3115 mL | 35.8623 mL | 17.9311 mL |
Contact our team with the catalog number and requested quantity.